In the process of metastatic progression, FN acts as a potent guidance and motility cure for cancer cells via ECM remodeling and ECM-guided directional migration [3]; FN independently indicates unfavorable clinical outcomes in nasopharyngeal carcinoma [4] and head and neck squamous cell carcinomas [5]. This evidence concerns the gene FN1 and head and neck squamous cell carcinoma.